TURENNE ANDRE (President & CEO) sold 6.3% of their position (10.44K shares) of VOYAGER THERAPEUTICS, INC. on the open market
Open‑market sale worth $90.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/14/2021ACC: 0001104659-21-004321
DirectorOfficer· President & CEO
Since Jul 2018
-10.44K
Net shares
Net seller
$90.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10.44K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10.44K
Price / share
$8.62
Trade value
$90.02K
% of position
6.3%
1/12/2021
166.79K→156.35K
Total
Net shares
−10.44K
Net value
-$90.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/12/2021 | S · Sale | −10.44K | $8.62 | $90.02K | 6.3% | 166.79K | 156.35K |
| Total | −10.44K | -$90.02K | ||||||
Derivative Transactions0
No derivative transactions reported